[1]
Yohei Noguchi, “Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy? ”, Turkish Journal of Gastroenterology, vol. 27, no. 2, pp. 165–172, Jul. 2019.